FR2387653A1 - Solutions aqueuses steriles contenant une substance a base d'hydrates de carbone et destinees a etre administrees par voie parenterale ainsi que leur procede de preparation - Google Patents
Solutions aqueuses steriles contenant une substance a base d'hydrates de carbone et destinees a etre administrees par voie parenterale ainsi que leur procede de preparationInfo
- Publication number
- FR2387653A1 FR2387653A1 FR7810680A FR7810680A FR2387653A1 FR 2387653 A1 FR2387653 A1 FR 2387653A1 FR 7810680 A FR7810680 A FR 7810680A FR 7810680 A FR7810680 A FR 7810680A FR 2387653 A1 FR2387653 A1 FR 2387653A1
- Authority
- FR
- France
- Prior art keywords
- weight
- sterile aqueous
- substance based
- preparation
- intended
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007864 aqueous solution Substances 0.000 title abstract 2
- 239000000126 substance Substances 0.000 title abstract 2
- -1 CARBON HYDRATES Chemical class 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 title 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 4
- YGMBQDCBGPAZNW-YIBJATESSA-N (2r,3s,4r,5r)-2-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4,5,6-tetrakis[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]hexanal Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@H]([C@@H](O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@H](O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H](O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C=O)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YGMBQDCBGPAZNW-YIBJATESSA-N 0.000 abstract 2
- PIBXBCFBUUZPRF-UHFFFAOYSA-N isocyclomaltohexaose Natural products OCC1OC2OCC3OC(OC4C(O)C(O)C(OC4CO)OC5C(O)C(O)C(OC5CO)OC6C(O)C(O)C(OC6CO)OC7C(O)C(O)C(OC7CO)OC1C(O)C2O)C(O)C(O)C3O PIBXBCFBUUZPRF-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- DFKPJBWUFOESDV-NGZVDTABSA-N (2S,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@@H](OC[C@@H]3[C@H]([C@H](O)[C@@H](O)[C@@H](O)O3)O)O2)O)O1 DFKPJBWUFOESDV-NGZVDTABSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 abstract 1
- FBJQEBRMDXPWNX-FYHZSNTMSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-FYHZSNTMSA-N 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
Solution aqueuse stérile contenant une substance à base d'hydrates de carbone. La solution contient, pour 100 ml de solution, 0,01 à 35 g d'un mélange d'isomalto-oligosaccharides, lequel contient : a. 0 à 15 % en poids d'isomaltose, b. 20 à 65 % en poids d'isomaltotriose, d'isomaltotétraose et d'isomaltopentaose, chacun de ces oligosaccharides étant présents en une quantité comprise entre 5 et 25 % en poids, c. 20 à 65 % en poids d'isomaltohexaose, d'isomaltoheptaose, d'isomaltooctaose et d'isomaltononaose, l'isomaltohexaose et l'isomaltoheptaose étant présents en une quantité comprise entre 5 et 25 % en poids, et d. 0 à 30 % en poids d'isomalto-oligosaccharides renfermant de 10 à 20 maillons glucose, les pourcentages étant calculés sur le poids total du mélange d'isomalto-oligosaccharides. L'invention est applicable à des traitements médicaux par voie parentérale.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB16162/77A GB1594697A (en) | 1977-04-19 | 1977-04-19 | Oligosaccharide compositions for parenteral use |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2387653A1 true FR2387653A1 (fr) | 1978-11-17 |
FR2387653B1 FR2387653B1 (fr) | 1980-08-01 |
Family
ID=10072281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7810680A Granted FR2387653A1 (fr) | 1977-04-19 | 1978-04-11 | Solutions aqueuses steriles contenant une substance a base d'hydrates de carbone et destinees a etre administrees par voie parenterale ainsi que leur procede de preparation |
Country Status (14)
Country | Link |
---|---|
US (1) | US4201772A (fr) |
JP (1) | JPS542314A (fr) |
AT (1) | AT370114B (fr) |
BE (1) | BE866092A (fr) |
CA (1) | CA1094452A (fr) |
CH (1) | CH641353A5 (fr) |
DE (1) | DE2815967C2 (fr) |
DK (1) | DK158627C (fr) |
ES (1) | ES468867A1 (fr) |
FR (1) | FR2387653A1 (fr) |
GB (1) | GB1594697A (fr) |
IT (1) | IT1103077B (fr) |
NL (1) | NL188387C (fr) |
SE (1) | SE443509B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE427983B (sv) * | 1980-02-15 | 1983-05-30 | Pripps Bryggerier Ab | Dryckesprodukt |
DE3113035A1 (de) * | 1981-04-01 | 1982-10-21 | Laboratorien Hausmann AG, 9001 St. Gallen | Verfahren zur herstellung eines hohen anteil an isomaltopentaose und isomaltohexaose aufweisenden gemisches, dessen verwendung und es enthaltende sterile waessrige loesung |
US4518581A (en) * | 1981-11-02 | 1985-05-21 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Imparting low- or anti-cariogenic property to orally-usable products |
JPS61227777A (ja) * | 1985-04-02 | 1986-10-09 | Showa Sangyo Kk | ビフイズス菌生育活性剤 |
JPS63143505U (fr) * | 1987-03-11 | 1988-09-21 | ||
EP0928222B2 (fr) * | 1995-09-12 | 2007-03-21 | M&J Industries A/S | Broyeuse |
JPH11100401A (ja) * | 1997-07-30 | 1999-04-13 | Kikkoman Corp | 環状オリゴ糖及びそれを含むレトロウイルス性疾患の予防または治療剤 |
US20030203072A1 (en) * | 2002-04-26 | 2003-10-30 | Team Nrg, Inc. | Rehydration beverage |
UA103373C2 (ru) | 2009-03-25 | 2013-10-10 | Фармакосмос Голдинг А/С | Стабильное соединение феррума олигосахарида |
GB201020300D0 (en) | 2010-11-30 | 2011-01-12 | Vitrolife Sweden Ab | Product |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2708174A (en) * | 1952-11-15 | 1955-05-10 | Commercial Solvents Corp | Clinical dextran composition |
-
1977
- 1977-04-19 GB GB16162/77A patent/GB1594697A/en not_active Expired
-
1978
- 1978-03-23 SE SE7803404A patent/SE443509B/sv not_active IP Right Cessation
- 1978-03-28 US US05/891,106 patent/US4201772A/en not_active Expired - Lifetime
- 1978-03-30 CA CA300,093A patent/CA1094452A/fr not_active Expired
- 1978-04-11 FR FR7810680A patent/FR2387653A1/fr active Granted
- 1978-04-12 CH CH390178A patent/CH641353A5/de not_active IP Right Cessation
- 1978-04-13 DE DE2815967A patent/DE2815967C2/de not_active Expired
- 1978-04-17 ES ES468867A patent/ES468867A1/es not_active Expired
- 1978-04-17 AT AT0268678A patent/AT370114B/de not_active IP Right Cessation
- 1978-04-18 BE BE186874A patent/BE866092A/fr not_active IP Right Cessation
- 1978-04-18 IT IT09419/78A patent/IT1103077B/it active
- 1978-04-18 JP JP4643078A patent/JPS542314A/ja active Granted
- 1978-04-18 NL NLAANVRAGE7804147,A patent/NL188387C/xx not_active IP Right Cessation
- 1978-04-18 DK DK169378A patent/DK158627C/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA1094452A (fr) | 1981-01-27 |
SE443509B (sv) | 1986-03-03 |
IT7809419A0 (it) | 1978-04-18 |
NL188387C (nl) | 1992-06-16 |
SE7803404L (sv) | 1978-10-20 |
ES468867A1 (es) | 1979-09-16 |
AT370114B (de) | 1983-03-10 |
DK169378A (da) | 1978-10-20 |
US4201772A (en) | 1980-05-06 |
NL7804147A (nl) | 1978-10-23 |
DE2815967A1 (de) | 1978-10-26 |
JPS542314A (en) | 1979-01-09 |
FR2387653B1 (fr) | 1980-08-01 |
ATA268678A (de) | 1980-09-15 |
CH641353A5 (de) | 1984-02-29 |
GB1594697A (en) | 1981-08-05 |
DK158627C (da) | 1990-11-19 |
DE2815967C2 (de) | 1986-07-31 |
BE866092A (fr) | 1978-10-18 |
JPS6237007B2 (fr) | 1987-08-10 |
IT1103077B (it) | 1985-10-14 |
DK158627B (da) | 1990-06-25 |
NL188387B (nl) | 1992-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Barker et al. | The mechanism of auricular paroxysmal tachycardia | |
Perkins | Serious verapamil poisoning: treatment with intravenous calcium gluconate | |
Surawicz et al. | Effect of potassium and calcium deficiency on the monophasic action potential, electrocardiogram and contractility of isolated rabbit hearts | |
FR2387653A1 (fr) | Solutions aqueuses steriles contenant une substance a base d'hydrates de carbone et destinees a etre administrees par voie parenterale ainsi que leur procede de preparation | |
BELLET | The electrocardiogram in electrolyte imbalance | |
Barnes et al. | Electrocardiographic changes in amitriptyline poisoning | |
FR2406999A1 (fr) | Stabilisant pour polysaccharides de meningocoques | |
Niwa et al. | A new potent β-glucuronidase inhibitor, D-glucaro-δ-lactam derived from nojirimycin | |
McKusick | The effect of lithium on the electrocardiogram of animals and relation of this effect to the ratio of the intracellular and extracellular concentrations of potassium | |
Page et al. | Interrelationships between cardiac effects of ouabain, hypocalcemia and hyperkalemia | |
Staley et al. | Crossbands of Caulobacter crescentus stalks serve as indicators of cell age | |
OLINGER | Mixed infection in subacute bacterial endocarditis: report of two cases | |
GB1378068A (en) | Citric acid derivatives | |
Kleinfeld et al. | Electrocardiographic manifestations of hypocalcemia produced with ethylenediamine tetraacetic acid | |
FR2401139A2 (fr) | Nouveaux derives d5 de prostaglandines, leur procede de preparation et medicaments les contenant | |
Bellet et al. | Effect of molar sodium lactate in increasing cardiac rhythmicity: Clinical and experimental study of its use in the treatment of patients with slow heart rates, Stokes-Adams syndrome, and episodes of cardiac arrest | |
Burghuber et al. | Decreased prostacyclin sensitivity of human platelets after jogging and squash | |
Senges et al. | Combined effects of glucose and hypoxia on cardiac automaticity and conduction | |
FR2372629A1 (fr) | Nouvel antibiotique et son procede de preparation | |
Prasad et al. | Electrophysiologic basis of use of a polarizing solution in the treatment of myocardial infarction | |
FR2414556A1 (fr) | Procede de preparation d'hydrolysats d'amidon contenant du maltose, et de production de maltose par cristallisation a partir de ces hydrolysats | |
Follath et al. | Unusual electrocardiographic changes in Ebstein's anomaly | |
KR880013562A (ko) | 7-티아프로스타글란딘e₁ 또는 그의 유도체를 함유하는 당뇨병치료 조성물 | |
KR880013936A (ko) | 강심성 트리사이클릭 이미다졸론 | |
Giacoia et al. | Q-oTc interval and blood calcium levels in newborn infants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
CC | Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990) |
Free format text: 92C0462, 920619 |
|
CB | Supplementary protection certificate (spc) granted (law of 25 june 1990) |
Free format text: 92C0462, 780411 |
|
CL | Concession to grant licences | ||
CD | Change of name or company name | ||
TP | Transmission of property |